[{"address1": "4902 Eisenhower Boulevard", "address2": "Suite 125", "city": "Tampa", "state": "FL", "zip": "33634", "country": "United States", "phone": "813 286 7900", "fax": "813 286 7904", "website": "https://www.oragenics.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Oragenics, Inc., a development-stage company, engages in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases in the United States. Its lead product is ONP-002, a fully synthetic, non-naturally occurring neurosteroid which is lipophilic and can cross the blood-brain barrier to reduce swelling, oxidative stress, and inflammation while restoring proper blood flow through gene amplification. The company also develops NT-CoV2-1, a SARS-CoV-2 vaccine product candidate; and Lantibiotic Product Candidate, such as Mutacin 1140 (MU1140), a molecule belonging to the novel class of antibiotics. It has a license agreement with Inspirevax Inc. The company was formerly known as Oragen, Inc. Oragenics, Inc. was incorporated in 1996 and is headquartered in Tampa, Florida.", "fullTimeEmployees": 5, "companyOfficers": [{"maxAge": 1, "name": "Mr. Charles L. Pope CPA", "age": 71, "title": "Executive Chairman", "yearBorn": 1952, "fiscalYear": 2023, "totalPay": 112500, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Joseph Michael Redmond", "age": 62, "title": "President & Interim Principal Executive Officer", "yearBorn": 1961, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 9611}, {"maxAge": 1, "name": "Ms. Janet  Huffman", "age": 51, "title": "CFO, Secretary & Treasurer", "yearBorn": 1972, "fiscalYear": 2023, "totalPay": 314896, "exercisedValue": 0, "unexercisedValue": 4554}, {"maxAge": 1, "name": "Dr. James P. Kelly M.A., M.D.", "title": "Chief Medical Officer & Member of Scientific Advisor", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "irWebsite": "http://www.oragenics.com/?q=investors", "maxAge": 86400, "priceHint": 4, "previousClose": 1.07, "open": 1.1, "dayLow": 1.0601, "dayHigh": 1.1799, "regularMarketPreviousClose": 1.07, "regularMarketOpen": 1.1, "regularMarketDayLow": 1.0601, "regularMarketDayHigh": 1.1799, "beta": 0.323, "forwardPE": -0.1, "volume": 36916, "regularMarketVolume": 36916, "averageVolume": 86453, "averageVolume10days": 22800, "averageDailyVolume10Day": 22800, "bidSize": 3100, "askSize": 1100, "marketCap": 4839145, "fiftyTwoWeekLow": 1.0, "fiftyTwoWeekHigh": 7.74, "priceToSalesTrailing12Months": 128.5195, "fiftyDayAverage": 1.3882, "twoHundredDayAverage": 3.22835, "currency": "USD", "enterpriseValue": 3270884, "floatShares": 3949193, "sharesOutstanding": 4480690, "sharesShort": 35608, "sharesShortPriorMonth": 58583, "sharesShortPreviousMonthDate": 1710460800, "dateShortInterest": 1713139200, "sharesPercentSharesOut": 0.007900001, "heldPercentInsiders": 0.23231001, "heldPercentInstitutions": 0.07375, "shortRatio": 0.55, "shortPercentOfFloat": 0.009, "impliedSharesOutstanding": 4480690, "bookValue": 0.511, "priceToBook": 2.1135032, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1703980800, "netIncomeToCommon": -20655736, "trailingEps": -9.18, "forwardEps": -10.8, "lastSplitFactor": "1:60", "lastSplitDate": 1674432000, "enterpriseToRevenue": 86.869, "enterpriseToEbitda": -0.157, "52WeekChange": -0.70277774, "SandP52WeekChange": 0.24486005, "exchange": "ASE", "quoteType": "EQUITY", "symbol": "OGEN", "underlyingSymbol": "OGEN", "shortName": "Oragenics Inc.", "longName": "Oragenics, Inc.", "firstTradeDateEpochUtc": 1077719400, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "747ffae6-a5e0-3f81-bef4-ef8201719134", "messageBoardId": "finmb_774436", "gmtOffSetMilliseconds": -14400000, "currentPrice": 1.08, "recommendationMean": 2.0, "recommendationKey": "buy", "totalCash": 3483501, "totalCashPerShare": 0.777, "ebitda": -20877512, "totalDebt": 322514, "quickRatio": 1.937, "currentRatio": 2.15, "totalRevenue": 37653, "debtToEquity": 10.18, "revenuePerShare": 0.017, "returnOnAssets": -1.3248199, "returnOnEquity": -2.55364, "freeCashflow": -9226470, "operatingCashflow": -7290880, "operatingMargins": -555.19885, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-05-07"}]